Furthermore, GLP1-RAs are effective at inducing body weight loss and improving insulin sensitivity, which may have kidney and cardiovascular benefits in type 1 diabetes
Common reasons Dose too low - may need to increase to therapeutic levels (2.4mg or higher) Not enough time - meaningful results typically take 8-12 weeks at adequate doses Calorie-dense liquid calories bypassing satiety signals - watch smoothies, alcohol, sugary drinks Eating through fullness signals - pay attention to your body's cues Inconsistent dosing schedule - must be same day each week for optimal levels Unrealistic expectations - 1-2 lbs per week is healthy, sustainable weight loss Key Research [1]"Once-weekly cagrilintide for weight management in people with overweight and obesity" Lau DCW et al., 2021 Finding: Phase 2 trial showed cagrilintide at 4.5mg achieved 10.8% weight loss versus 3% with placebo over 26 weeks in 706 participants
"The Impact of Omega-3 Fatty Acids on Cellular Uptake Mechanisms: Implications for Nutrient Absorption." Advances in Nutrition Research, 8(2), 123-138
During the semaglutide shortage, its possible that many people may have experienced worsening health outcomes without compounded semaglutide
Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet